People with mild or moderate hemophilia may struggle to get prophylactic treatment because their disease severity classification does not always match their bleeding symptoms. Additionally, racial and ethnic minority groups with hemophilia often face systemic and socioeconomic circumstances that prevent them from accessing optimized care. It is important for healthcare providers to recognize the barriers to appropriate hemophilia treatment and take actionable steps to overcome institutional, social, economic, and other roadblocks so that all patients can benefit from advances in therapy. In this 30-minute CME Snack video, experts in hemophilia explore new and emerging therapies that can improve outcomes for patients with hemophilia. A case study presentation provides additional clinical perspective and offers ways to provide equitable treatment in underserved patient groups.
- Provider:CME Outfitters, LLC
- Activity Link: https://www.cmeoutfitters.com/activity/does-labeling-the-level-of-severity-in-hemophilia-block-access-to-optimized-care/
- Start Date: 2024-07-12 05:00:00
- End Date: 2024-07-12 05:00:00
- Credit Details: IPCE Credits: 0.5 hours
AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Novo Nordisk (Any division) - Amount: 0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine